Krishna Institute of Medical Sciences (KIMS Hospitals) has announced its financial results for the first quarter, reporting strong revenue growth but a decline in profitability.

Financial Highlights

• Total revenue reached ₹879.00 crores, representing a 26.8% year-on-year growth and 9.6% quarter-on-quarter growth.
• EBITDA stood at ₹200.00 crores, showing 8.5% YoY growth but a 1.4% QoQ decline.
• EBITDA margin compressed to 22.7% from 26.6% in the same quarter of the previous year and 25.3% in the preceding quarter.
• Profit after tax decreased to ₹85.00 crores from ₹95.00 crores in the same quarter of the previous year and ₹106.00 crores in the preceding quarter.
• Consolidated earnings per share stood at ₹1.96, down 9.2% YoY.

Operational Performance

KIMS Hospitals reported strong operational metrics:

• Inpatient volume grew 15.3% YoY to 57,275.
• Outpatient volume increased 19.3% YoY to 5,02,492.
• Average revenue per occupied bed (ARPOB) rose 11.8% YoY to ₹43,011.00.

Financial Position

The company reported cash and equivalents totaling ₹70.00 crores.

Management Commentary

Dr. B Bhaskar Rao, CMD of KIMS Hospitals, noted robust performance despite the seasonally lean quarter and confirmed that two Bangalore units will commence operations in the next quarter.

Board Meeting and Result Approval

The Board of Directors of Krishna Institute of Medical Sciences convened on August 6 to review and approve the financial results. The meeting, which began at 1:30 PM and concluded at 2:30 PM, saw the approval of unaudited standalone and consolidated financial results for the quarter ended June 30.

Transparency and Compliance

In line with regulatory requirements, KIMS has made its financial results available on the company's official website ( https://www.kimshospitals.com/investors/Disclosures ) under the Financial Information section. The results are also accessible on the websites of BSE Ltd ( www.bseindia.com ) and the National Stock Exchange of India Ltd ( www.nseindia.com ).

Upcoming Investor Meeting

KIMS has informed stakeholders about an upcoming Analyst/Institutional Investor Meeting. The company is scheduled to participate in the Emkay Confluence, a group meeting to be held in Mumbai on August 12. This event provides an opportunity for analysts and institutional investors to gain insights into the company's performance and future outlook.

Conclusion

While Krishna Institute of Medical Sciences has experienced strong revenue growth, the company faces challenges in maintaining profitability. The expansion plans with new units in Bangalore and continued focus on operational metrics demonstrate KIMS Hospitals' commitment to growth and improved healthcare delivery. Stakeholders will be closely monitoring the company's performance in the coming quarters as it navigates the competitive healthcare landscape.

Krishna Institute of Medical Sciences Ltd. (KIMS) witnessed a significant block trade on the National Stock Exchange (NSE) today, marking a notable event in the company's recent trading activity.

Block Trade Details

A substantial block of approximately 797,020 shares of KIMS changed hands in a single transaction. The trade was executed at a price of ₹647.65 per share, resulting in a total transaction value of ₹51.62 crore.

Market Impact

Block trades of this magnitude often attract attention from market participants as they can indicate significant investor interest or potential changes in substantial shareholdings. However, it's important to note that the specific reasons behind this large trade and the identities of the involved parties remain undisclosed at this time.

About Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences Ltd. is a prominent healthcare provider in India. The company operates a chain of multi-specialty hospitals, offering a wide range of medical services. KIMS has been expanding its presence in the healthcare sector, focusing on providing quality medical care across various specialties.

Investor Considerations

While this block trade represents a significant transaction, investors and market analysts will likely be watching for any subsequent disclosures or regulatory filings that might provide more context to this development. As always, market participants are advised to conduct their own research and consider multiple factors when making investment decisions.

The occurrence of such a substantial trade may spark discussions about the company's perceived value and future prospects in the healthcare sector. However, it's crucial to remember that block trades can occur for various reasons and may not necessarily reflect on the company's operational performance or future outlook.